An interventional study of Smoking cessation intervention and Informational intervention in Cancer and Smoking Cessation, sponsored by Medical University of South Carolina. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.
Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of the current study is to pilot the efficacy, feasibility, and acceptability of an evidence-based smoking cessation intervention adapted for cancer patients and delivered via video. Investigators aim to assess if this intervention is considered acceptable by participants, feasible to implement, and effective at increasing knowledge about smoking cessation before conducting a fully powered clinical trial.
A randomized controlled pilot study is being conducted to test the acceptability and feasibility of a smoking cessation intervention tailored for cancer patients that is delivered via video. Participants will be in a video intervention or control group that receives information about quitting smoking. Participants will complete surveys prior to randomization, and will complete additional surveys one week, one month, and three months post-randomization to provide their thoughts about the videos, information about changes to smoking behaviors, and knowledge about quitting smoking.
10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.
This study's enrollment of 40 is below the median of 60 across 7,716 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →Medical University of South Carolina is the lead sponsor of 875 studies on the registry; 165 are open to participants now.
Of its 132 completed or terminated interventional studies of FDA-regulated products, 104 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- Unstable or poorly managed medical or psychiatric conditions that impair cognition and ability to provide (e.g., dementia, active psychosis).
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will be sent links to smoking cessation videos to watch.
Other: Smoking cessation intervention
Participants will be sent links to NCI's "Clearing the Air" to read.
Other: Informational intervention
Receive links to smoking cessation videos
Receive NCI's "Clearing the Air" booklet
Acceptability of Intervention Measure
Acceptability will be measured using the measure titled the "Acceptability of Intervention Measure" (AIM), which contains four items with answer options on a scale from 1-5. Higher scores indicating higher acceptability. We will consider the intervention "acceptable" if an average score of 4 or higher is obtained.
Time frame: 1 week post-randomization
Feasibility of Intervention Measure
Feasibility will be measured using the measure title the "Feasibility of Intervention Measure" (FIM), which contains four items with answer options on a scale from 1-5. Answer responses are summed and averaged. Higher scores indicating higher feasibility. We will consider the intervention "feasible" if an average score of 4 or higher is obtained.
Time frame: 1 week post-randomization
Number of Participants Retained
We will determine if there are differences in retention rates between intervention groups.
Time frame: 1 week, 1 month, and 3 months post-randomization
Number of Questions About Knowledge Related to Quitting Smoking That Were Answered Correctly
Questions about the impact of quitting smoking were asked to determine if there were numeric differences in the number of participants who answered each question correctly between intervention and control groups at 1-week follow-ups. Questions were true or false questions generated by the primary investigator. We calculated the number of participants who answered each of the three questions correctly.
Time frame: 1 week
Number of Participants Who Made Quit Attempts and Achieved Smoking Abstinence at 1-week, 1-month, and 3-month Follow-ups
We calculated the number of 24-hour quit attempts made by participants in each group at the 1-week, 3-month, and 6-month follow-ups. We also calculated the number of participants who reported past 7-day point prevalence abstinence at 1-week, 1-month, and 3-month follow-ups.
Time frame: 1 week, 1 month, and 3 months post-randomization
Participants were recruited through the Tobacco Treatment Program at the Medical University of South Carolina Hollings Cancer Center. All cancer center patients that received a call from a tobacco treatment specialist as part of the cancer center's standard of care were asked about their interest in participating in a research study, and interested patients were referred to study staff. Participants were recruited between September 2024 and June 2025.
| Milestone | Videos | NCI Pamphlet |
|---|---|---|
| Started | 20 | 20 |
| Completed | 20 | 20 |
| Not completed | 0 | 0 |
Acceptability will be measured using the measure titled the "Acceptability of Intervention Measure" (AIM), which contains four items with answer options on a scale from 1-5. Higher scores indicating higher acceptability. We will consider the intervention "acceptable" if an average score of 4 or higher is obtained.
| score on a scale | Videos | NCI Pamphlet |
|---|---|---|
| Acceptability of Intervention Measure | 4.2 ± 0.54 | 3.9 ± 0.52 |
Feasibility will be measured using the measure title the "Feasibility of Intervention Measure" (FIM), which contains four items with answer options on a scale from 1-5. Answer responses are summed and averaged. Higher scores indicating higher feasibility. We will consider the intervention "feasible" if an average score of 4 or higher is obtained.
| score on a scale | Videos | NCI Pamphlet |
|---|---|---|
| Feasibility of Intervention Measure | 4.0 ± 0.53 | 3.8 ± 0.45 |
We will determine if there are differences in retention rates between intervention groups.
| participants | Videos | NCI Pamphlet |
|---|---|---|
| 1-week retention | 18 | 16 |
| 1-month retention | 14 | 12 |
| 3-months retention | 15 | 12 |
Questions about the impact of quitting smoking were asked to determine if there were numeric differences in the number of participants who answered each question correctly between intervention and control groups at 1-week follow-ups. Questions were true or false questions generated by the primary investigator. We calculated the number of participants who answered each of the three questions correctly.
| participants | Videos | NCI Pamphlet |
|---|---|---|
| Smoking impact on anxiety question correct | 12 | 8 |
| Smoking impact on cancer treatment correct | 18 | 15 |
| Safe to use multiple forms of NRT correct | 10 | 8 |
We calculated the number of 24-hour quit attempts made by participants in each group at the 1-week, 3-month, and 6-month follow-ups. We also calculated the number of participants who reported past 7-day point prevalence abstinence at 1-week, 1-month, and 3-month follow-ups.
| participants | Videos | NCI Pamphlet |
|---|---|---|
| 1-week quit attempts | 4 | 5 |
| 1-month quit attempts | 6 | 4 |
| 3-month quit attempts | 8 | 7 |
| 1-week abstinence | 1 | 3 |
| 1-month abstinence | 0 | 2 |
| 3-months abstinence | 2 | 2 |
Collected over Adverse events were not collected given the study was a low-risk behavioral intervention study assessing acceptability and feasibility of using video for smoking cessation.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Videos | — | — | — |
| NCI Pamphlet | — | — | — |
Two participants that completed baseline surveys were considered randomized non-starters given they did not receive or participate in study procedures due to dropout or death. Their data were not analyzed with the rest of the sample.
| Age, Continuous(years) | Videos | NCI Pamphlet | Total |
|---|---|---|---|
| Mean | 54.7 ± 10 | 59.6 ± 6.8 | 57.1 ± 8.8 |
| Sex: Female, Male(Participants) | Videos | NCI Pamphlet | Total |
|---|---|---|---|
| Female | 12 | 8 | 20 |
| Male | 8 | 12 | 20 |
| Race (NIH/OMB)(Participants) | Videos | NCI Pamphlet | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 9 | 8 | 17 |
| White | 10 | 11 | 21 |
| More than one race | 1 | 1 | 2 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Rural/Urban Residence(Participants) | Videos | NCI Pamphlet | Total |
|---|---|---|---|
| Rural | 7 | 7 | 14 |
| Urban | 13 | 13 | 26 |
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Sep 2024 to primary completion in Sep 2025, 11 months.
Results were first posted in Sep 2026, 1 year after primary completion.
Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's 11 months is below that.
Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of South Carolina →